CFTR and cystic fibrosis: In 2023, Maze et al. developed a CFTR-encoding plasmid for CF gene therapy which demonstrated the ability to produce a fully glycosylated C form of the CFTR protein in human bronchial epithelial cells during preclinical trials, confirming its capability for selective tissue expression [33].